Research

2023

Cancer Council Tasmania Research Grant

• Project: Identifying key drivers of metastatic bone lesions from several cancer types. 
• Research team: Dr Kelsie Raspin, Professor Jo Dickinson, Dr Liesel FitzGerald, A/Prof Louise Nott
• Funding awarded: $13,900

2022

Cancer Council Tasmania Research Grant

• Project: Co-design of an educational intervention to improve bowel cancer awareness and screening in a rural community.
• Research team: Dr Kehinde Obamiro, Dr Simone Lee, Dr Matt Sharman
• Funding awarded: $25,000

Cancer Council Tasmania Research Grant

• Project: Understanding TMPRSS2:ERG gene fusions to improve prostate cancer diagnosis and treatment options.
• Research team: Dr Liesel Fitzgerald, Professor Jo Dickinson, Dr Kelsie Raspin
• Funding awarded: $24,776

2021

The Dorothy Ryan Research Award

• Project: The experiences of an integrated care model for people who have a diagnosis of cancer in southern Tasmania. 
• Research team: Janet Clemens, Donna Gallagher, Laurie Steven Bourke, Rebecca Clarke, Annalee Graham, Bronwen Neely, Clinical Associate Professor Rosemary Harrup, Dr Briony Campbell
• Funding awarded: $11,000

The Simon Hrycyszyn Research Award

• Project: Repurposing of FDA approved drugs against medulloblastoma.
• Research team: Dr Iman Azimi, Associate Professor Nuri Gueven, Mohammed Sedeeq
• Funding awarded: $14,828

The Prospect Timber & Landscaping Research Award

• Project: Applying innovative ‘omics’ technologies to identify key molecular drivers of metastatic bone tumours.
• Research team: Dr Kelsie Raspin, Professor Jo Dickinson, Dr Liesel Fitzgerald, A/Prof Adele Holloway
• Funding awarded: $14,778

The UCI Tasmania Research Award

• Project: Examining DNA hydroxymethylation as a radiosensitisation target in medulloblastoma.
• Research team: Dr Kate Brettingham-Moore, A/Prof Phillippa Taberlay, A/Prof Adele Holloway
• Funding awarded: $11,000

Cancer Council Tasmania Research Grant

• Project: DNA Damage Repair Gene Variants in Clinically Significant Prostate Cancer.
• Research team: Professor Jo Dickinson, Dr Liesel Fitzgerald
• Funding awarded: $9,608

2023

To be announced

2022

• Cancer Council Tasmania/Searoad Honours Scholarship: awarded to Daisy Nowakowski ($10,000)
• Cancer Council Tasmania/Mazengarb Family Honours Scholarship: awarded to Jasmine Bacon ($10,000)
• Cancer Council Tasmania Joy and Robert Coghlan/UTAS College of Health and Medicine Postdoctoral Research Fellowship: awarded to Dr Kelsie Raspin ($200,000 over 2 years)
• Cancer Council Tasmania/Evelyn Pedersen Postgraduate Scholarship and College of Health and Medicine co-funded scholarship: awarded to Sophie Navickas ($52,500)

2021

• Pat Campbell Honours Scholarship: Chloe Maisey ($10,000)

1. Foley GR, Marthick JR, Lucas SE, Raspin K, Banks A, Stanford JL, Ostrander EA, FitzGerald LM, Dickinson JL, ‘Germline sequencing of DNA-damage-repair genes in two hereditary prostate cancer cohorts reveals rare risk-associated variants’ MedXriv (Preprint) 2023 DOI: 10.1101/2022.04.11.22273677
2. Challis D, Lippis T, Wilson R, Wilkinson E, Dickinson J, Black A, Azimi I, Holloway A, Taberlay P, Brettingham-Moore K, ‘Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells’ Epigenetics, 18(1):2214047. (2023) DOI: 10.1080/15592294.2023.2214047
3. Gadd N, Lee S, Obamiro K, 'Perception of bowel cancer information overload: A cross-sectional study', Journal of Consumer Health on the Internet, 26, (3) pp. 235-247. ISSN 1539-8285 (2022) DOI: 10.1080/15398285.2022.2073709
4. Lee SM, Versace VL, Obamiro K, 'Public awareness of bowel cancer risk factors, symptoms and screening in Tasmania, Australia: a cross-sectional study', International Journal of Environmental Research and Public Health, 19, (3) Article 1497. ISSN 1660-4601 (2022) DOI: 10.3390/ijerph19031497
5. Ezegbe C, Neil AL, Magnussen CG, Chappell K, Judd F, et al., 'Maternal smoking in pregnancy and child's hospital use up to 5 years of age in a data linkage birth cohort', Hospital Pediatrics, 11, (1) pp. 8-16. ISSN 2154-1663 (2021) DOI: 10.1542/hpeds.2020-0150
6. Raspin K, FitzGerald LM, Marthick JR, Field MA, Malley RC, Banks A, Donovan S, Thomson RJ, Foley GR, Stanford JL, Dickinson JL. A rare variant in EZH2 is associated with prostate cancer risk. Int J Cancer. 2021 Sep 1;149(5):1089-1099. DOI: 10.1002/ijc.33584.
7. Breen, R and Ferguson, SG and Palmer, MA, ‘Higher incentive amounts do not appear to be associated with greater quit rates in financial incentive programmes for smoking cessation’ Addictive Behaviors, 110 pp. 1-6. ISSN 0306-4603 (2020) DOI:10.1016/j.addbeh.2020.106513
8. Wilkinson EJ, Woodworth AM, Parker M, Phillips JL, Malley RC, Dickinson JL, Holloway AF, 'Epigenetic regulation of the ITGB4 gene in prostate cancer', Experimental Cell Research, 392, (2) pp. 1-10. ISSN 0014-4827 (2020) DOI: 0.1016/j.yexcr.2020.112055.
9. Obamiro K, West S, Lee S, 'Like, comment, tag, share: Facebook interactions in health research', International Journal of Medical Informatics, 137 Article 104097. ISSN 1386-5056 (2020) DOI:10.1016/j.ijmedinf.2020.104097
10. Sutton LP, Jeffreys SA, Phillips JL, Taberlay PC, Holloway AF, Ambrose M, Ji-Hoon Joo E, Young A, Berry R, Skala M, Brettingham-Moore K, 'DNA methylation changes following DNA damage in prostate cancer cells', Epigenetics, 14, (10) pp. 989-1002. ISSN 1559-2294 (2019) DOI:10.1080/15592294.2019.1629231